- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.49 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NOF: tert-butyl 7'-[5-[(3aS,4S,6aR)-2-oxidanylidene-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-1-chloranyl-2,3,4,5,6-pentamethyl-spiro[1$l^{8}-iridapentacyclo[2.2.0.0^{1,3}.0^{1,5}.0^{2,6}]hexane-1,2'-3-aza-1-azonia-2$l^{8}-iridatricyclo[6.3.1.0^{4,12}]dodeca-1(11),4,6,8(12),9-pentaene]-3'-carboxylate(Non-covalent)
- 8 x SO4: SULFATE ION(Non-functional Binders)
SO4.2: 3 residues within 4Å:- Chain A: G.37, A.39, R.73
1 PLIP interactions:1 interactions with chain A- Salt bridges: A:R.73
SO4.3: 4 residues within 4Å:- Chain A: W.109, K.110
- Chain C: V.36, G.37
4 PLIP interactions:3 interactions with chain A, 1 interactions with chain C- Water bridges: A:W.109, A:W.109
- Salt bridges: A:K.110
- Hydrogen bonds: C:G.37
SO4.5: 3 residues within 4Å:- Chain B: G.37, A.39, R.73
1 PLIP interactions:1 interactions with chain B- Salt bridges: B:R.73
SO4.6: 4 residues within 4Å:- Chain B: W.109, K.110
- Chain D: V.36, G.37
4 PLIP interactions:1 interactions with chain D, 3 interactions with chain B- Hydrogen bonds: D:G.37
- Water bridges: B:W.109, B:W.109
- Salt bridges: B:K.110
SO4.8: 3 residues within 4Å:- Chain C: G.37, A.39, R.73
1 PLIP interactions:1 interactions with chain C- Salt bridges: C:R.73
SO4.9: 4 residues within 4Å:- Chain A: V.36, G.37
- Chain C: W.109, K.110
4 PLIP interactions:1 interactions with chain A, 3 interactions with chain C- Hydrogen bonds: A:G.37
- Water bridges: C:W.109, C:W.109
- Salt bridges: C:K.110
SO4.11: 3 residues within 4Å:- Chain D: G.37, A.39, R.73
1 PLIP interactions:1 interactions with chain D- Salt bridges: D:R.73
SO4.12: 4 residues within 4Å:- Chain B: V.36, G.37
- Chain D: W.109, K.110
4 PLIP interactions:3 interactions with chain D, 1 interactions with chain B- Water bridges: D:W.109, D:W.109
- Salt bridges: D:K.110
- Hydrogen bonds: B:G.37
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Igareta, N.V. et al., streptavidin mutant S112I with an iridium catalyst for CH activation. To Be Published
- Release Date
- 2023-12-20
- Peptides
- Streptavidin: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.49 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NOF: tert-butyl 7'-[5-[(3aS,4S,6aR)-2-oxidanylidene-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-1-chloranyl-2,3,4,5,6-pentamethyl-spiro[1$l^{8}-iridapentacyclo[2.2.0.0^{1,3}.0^{1,5}.0^{2,6}]hexane-1,2'-3-aza-1-azonia-2$l^{8}-iridatricyclo[6.3.1.0^{4,12}]dodeca-1(11),4,6,8(12),9-pentaene]-3'-carboxylate(Non-covalent)
- 8 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Igareta, N.V. et al., streptavidin mutant S112I with an iridium catalyst for CH activation. To Be Published
- Release Date
- 2023-12-20
- Peptides
- Streptavidin: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A